tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Verrica Pharmaceuticals Inc

VRCA
Add to Watchlist
4.450USD
-0.200-4.30%
Close 09-18 16:00（ET）
77.48MMarket Cap
LossP/E TTM

Verrica Pharmaceuticals Inc

4.450
-0.200-4.30%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

VRCA Financials

See Verrica Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
77.48M
Dividend TTM
0.00
P/E TTM
-4.08
EPS TTM
-1.11
Revenue
35.58M
Net Profit
-76.58M
ROE
-240.35%
ROA
-44.03%

Verrica Pharmaceuticals Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.62/-0.38
Revenue / Forecast
5.86M/5.73M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-2971.49%-0.62
55.76%-0.45
76.24%-0.57
99.41%-0.03
100.58%0.02
76.51%-1.03
54.79%-2.40
9.27%-4.88
-54.41%-3.70
-185.59%-4.37
-268.80%-5.31
---5.38
---2.39
---1.53
---1.44
---0.58
----
----
----
----
Revenue
-53.85%5.86M
46.06%5.02M
1380.23%5.09M
905.39%14.34M
145.35%12.70M
-10.12%3.44M
-82.70%344.00K
-161.06%-1.78M
2744.51%5.18M
10240.54%3.83M
2823.53%1.99M
-64.94%2.92M
-14.95%182.00K
-91.42%37.00K
--68.00K
--8.32M
--214.00K
-96.41%431.00K
--0.00
--0.00
Net Profit
-6547.55%-13.15M
0.62%-9.68M
50.17%-8.07M
98.80%-274.00K
101.19%204.00K
52.08%-9.74M
34.18%-16.20M
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-314.94%-24.61M
-29981.93%-24.80M
-8.08%-10.99M
22.21%-6.59M
37.82%-5.93M
100.65%83.00K
13.65%-10.17M
-804.91%-8.47M
26.49%-9.54M
-22.34%-12.83M
Net Margin
-14070.76%-224.38%
31.96%-192.75%
96.63%-158.56%
---1.91%
100.48%1.61%
46.69%-283.28%
-280.40%-4709.88%
----
94.50%-331.97%
97.02%-531.39%
85.81%-1238.13%
---850.26%
---6038.46%
---17808.11%
---8723.53%
---206.99%
----
----
----
----
Gross Margin
-11.54%85.02%
-5.72%82.30%
188.74%72.49%
--92.27%
7.35%96.11%
24.25%87.29%
-194.63%-81.69%
----
254.23%89.53%
183.85%70.26%
108.93%86.32%
--90.74%
--25.27%
---83.78%
---966.18%
--100.00%
----
----
----
----
Debt to assets ratio
-96.03%3.87%
-97.54%2.43%
-97.33%2.22%
-38.79%85.76%
12.16%97.55%
44.45%98.66%
53.34%83.20%
220.16%140.11%
--86.97%
--68.30%
--54.26%
--43.76%
----
----
--0.00%
--0.00%
----
----
----
----
Income Statement
Revenue
-53.85%5.86M
46.06%5.02M
1380.23%5.09M
905.39%14.34M
145.35%12.70M
-10.12%3.44M
-82.70%344.00K
-161.06%-1.78M
2744.51%5.18M
10240.54%3.83M
2823.53%1.99M
-64.94%2.92M
-14.95%182.00K
-91.42%37.00K
--68.00K
--8.32M
--214.00K
-96.41%431.00K
--0.00
--0.00
Operating profit
-854.90%-11.40M
-19.50%-9.71M
38.68%-6.95M
107.86%1.63M
109.93%1.51M
56.29%-8.13M
45.01%-11.33M
13.43%-20.70M
-30.91%-15.21M
-162.36%-18.60M
-231.65%-20.60M
-1751.73%-23.92M
-27.35%-11.62M
4.33%-7.09M
26.67%-6.21M
112.30%1.45M
15.00%-9.12M
-12450.00%-7.41M
29.61%-8.47M
-22.11%-11.77M
Net Profit
-6547.55%-13.15M
0.62%-9.68M
50.17%-8.07M
98.80%-274.00K
101.19%204.00K
52.08%-9.74M
34.18%-16.20M
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-314.94%-24.61M
-29981.93%-24.80M
-8.08%-10.99M
22.21%-6.59M
37.82%-5.93M
100.65%83.00K
13.65%-10.17M
-804.91%-8.47M
26.49%-9.54M
-22.34%-12.83M
Balance Sheet
Current assets
-11.26%32.64M
-13.54%34.13M
-16.88%42.54M
28.69%36.27M
-22.27%36.78M
-35.68%39.47M
-33.99%51.18M
-69.27%28.19M
-16.66%47.32M
-2.73%61.38M
98.21%77.53M
111.37%91.72M
-0.98%56.78M
-4.07%63.10M
-47.38%39.12M
-47.82%43.40M
-38.59%57.34M
-35.55%65.77M
9.87%74.33M
12.42%83.16M
Total current liabilities
-23.20%22.44M
-44.83%16.22M
-43.34%16.44M
37.49%28.91M
45.74%29.22M
51.80%29.40M
70.42%29.01M
84.86%21.03M
249.87%20.05M
632.69%19.36M
392.17%17.02M
269.53%11.37M
-87.46%5.73M
-94.10%2.64M
-92.49%3.46M
-93.36%3.08M
0.95%45.71M
0.32%44.80M
16.67%46.05M
18.90%46.37M
Total assets
-7.90%36.02M
-8.04%38.79M
-12.94%47.13M
24.20%40.90M
-24.81%39.11M
-36.39%42.18M
-33.66%54.13M
-66.11%32.93M
-16.38%52.01M
-3.40%66.31M
82.46%81.60M
97.67%97.15M
-1.95%62.20M
-4.16%68.64M
-44.19%44.72M
-44.63%49.15M
-35.94%63.44M
-33.75%71.62M
8.05%80.13M
11.03%88.76M
Total liabilities
-43.97%31.71M
-62.59%22.73M
-65.02%22.39M
-13.50%57.94M
-13.35%56.59M
-6.24%60.75M
3.49%63.99M
22.12%66.98M
860.30%65.31M
1608.38%64.80M
1218.98%61.83M
1151.60%54.84M
-85.56%6.80M
-91.79%3.79M
-90.13%4.69M
-90.85%4.38M
0.49%47.10M
-0.20%46.20M
15.43%47.52M
17.54%47.90M
Total equity
124.63%4.31M
186.43%16.05M
350.94%24.74M
49.96%-17.04M
-31.46%-17.48M
-1331.83%-18.58M
-149.89%-9.86M
-180.49%-34.05M
-124.01%-13.30M
-97.67%1.51M
-50.63%19.76M
-5.50%42.30M
239.19%55.40M
155.12%64.85M
22.78%40.03M
9.58%44.77M
-68.68%16.33M
-58.88%25.42M
-1.16%32.60M
4.26%40.85M
Cash Flow Statement
Net operating income
7.63%-9.28M
27.72%-9.16M
71.42%-4.59M
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-192.83%-14.51M
-911.56%-14.81M
34.98%-4.67M
44.96%-4.59M
43.04%-4.95M
117.22%1.82M
-387.35%-7.18M
22.67%-8.34M
-42.61%-8.70M
-39.30%-10.60M
Net investment
--0.00
--0.00
-100.00%0.00
100.00%0.00
100.00%0.00
----
103.52%8.00K
75.38%-16.00K
81.36%-11.00K
100.00%0.00
-103.36%-227.00K
-103.14%-65.00K
-102.68%-59.00K
-100.03%-11.00K
68.39%6.75M
-67.11%2.07M
109.96%2.21M
296.98%43.01M
567.48%4.01M
126.08%6.29M
Net financing
96.97%-126.00K
97.04%-120.00K
-65.40%13.64M
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
146122.22%39.43M
-100.90%-397.00K
-661.90%-640.00K
-102.18%-661.00K
---27.00K
361.37%44.04M
-8300.00%-84.00K
168322.22%30.28M
100.00%0.00
-39288.37%-16.85M
-100.41%-1.00K
-100.05%-18.00K
-100.67%-3.00K
--43.00K

FAQs

What is the total revenue of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 35.58M, with a year-on-year change of 7.57M.

What are the current assets of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its current assets were 42.54M, with a year-on-year change of -16.88.

What are the total assets of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its total assets of Verrica Pharmaceuticals Inc were 47.13M, with a year-on-year change of -12.94.

What are the total liabilities of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Verrica Pharmaceuticals Inc were 22.39M, with a year-on-year change of -65.02.

What is the total equity of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its total equity of Verrica Pharmaceuticals Inc was 24.74M, with a year-on-year change of 350.94.

What is the net operating income of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Verrica Pharmaceuticals Inc was -11.94M, with a year-on-year change of 81.87.

What is the net financing of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its net financing of Verrica Pharmaceuticals Inc was 1.45M, with a year-on-year change of -96.17.

What is the Earnings Per Share (EPS) of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.68, with a year-on-year change of 88.64.

What is the net income of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its net income was -17.89M, with a year-on-year change of 76.64.

What is the net margin of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -50.27, with a year-on-year change of 95.03.

What is the gross margin of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 90.33, with a year-on-year change of 41.61.

What is the debt-to-asset ratio of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 2.22, with a year-on-year change of -97.33.

What is the Return on Equity (ROE) of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -240.35, with a year-on-year change of 84.46.

What is the Return on Assets (ROA) of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.33, with a year-on-year change of 68.69.

What is the operating profit of Verrica Pharmaceuticals Inc?

According to Verrica Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -11.94M, with a year-on-year change of 81.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy